# Nuclide record pb-212 (isotope). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/isotopes/pb-212/>
  a schema:ChemicalSubstance ;
  nuclide:kind "isotope" ;
  schema:identifier "pb-212" ;
  schema:name "Lead-212"@en ;
  schema:alternateName "212Pb"@en, "Pb-212"@en ;
  schema:description "A radioactive metal that, once inside the body, turns itself into a much more damaging particle-emitter over the following hours. It is being explored as a way to deliver strong, short-range radiation without needing the rarer isotopes used in similar treatments."@en ;
  schema:url <https://nuclide.cc/isotopes/pb-212/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://pmc.ncbi.nlm.nih.gov/articles/PMC8777968/>, <https://perspectivetherapeutics.com/technology/manufacturing-logistics>, <https://www.isotopes.gov/node/123>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC12775822/> ;
  nuclide:status "phase-2" ;
  nuclide:tag "therapy", "alpha emitter", "in vivo generator" ;
  nuclide:related <https://nuclide.cc/drugs/alphamedix/>, <https://nuclide.cc/trials/alphamedix-02/>, <https://nuclide.cc/technologies/targeted-alpha-therapy/>, <https://nuclide.cc/isotopes/ra-224/>, <https://nuclide.cc/isotopes/bi-213/>, <https://nuclide.cc/ideas/idea-reg-alpha-emitter-portfolio/>, <https://nuclide.cc/companies/perspective-therapeutics/> .